These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 38964493)

  • 1. The FSCN1 gene rs2966447 variant is associated with increased serum fascin-1 levels and breast cancer susceptibility.
    Abdullah AR; Gamal El-Din AM; Ismail Y; El-Husseiny AA
    Gene; 2024 Nov; 927():148743. PubMed ID: 38964493
    [TBL] [Abstract][Full Text] [Related]  

  • 2. FSCN1 gene polymorphisms: biomarkers for the development and progression of breast cancer.
    Wang CQ; Tang CH; Wang Y; Jin L; Wang Q; Li X; Hu GN; Huang BF; Zhao YM; Su CM
    Sci Rep; 2017 Nov; 7(1):15887. PubMed ID: 29162880
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Genetic Polymorphism in FSCN1 rs3801004 C/G and CD44 rs353639 A/C, as Prognostic Factor in Egyptian Breast Cancer Patients.
    Ibrahim NE; Raafat Hamed RM; Refaat A; Mosaad YO; Mekawy DM
    Asian Pac J Cancer Prev; 2023 Oct; 24(10):3517-3523. PubMed ID: 37898858
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The association of FSCN1 (rs852479, rs1640233) and HOTAIR (rs920778) polymorphisms with the risk of breast cancer in Egyptian women.
    Galal ER; Abdelhakam DA; Ahmed LK; Elhusseny Y; Sayed SEP; Eltaweel NH
    Mol Biol Rep; 2024 Apr; 51(1):495. PubMed ID: 38587571
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The clinical signature of genetic variants and serum levels of macrophage migration inhibitory factor in Egyptian breast cancer patients.
    Seliem MA; Mohamadin AM; El-Sayed MIK; Ismail Y; El-Husseiny AA
    Breast Cancer Res Treat; 2024 Nov; 208(1):57-66. PubMed ID: 38916819
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Circulating Fascin 1 as a Promising Prognostic Marker in Adrenocortical Cancer.
    Cantini G; Fei L; Canu L; De Filpo G; Ercolino T; Nesi G; Mannelli M; Luconi M
    Front Endocrinol (Lausanne); 2021; 12():698862. PubMed ID: 34248854
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Significant association between ERCC2 and MTHR polymorphisms and breast cancer susceptibility in Moroccan population: genotype and haplotype analysis in a case-control study.
    Hardi H; Melki R; Boughaleb Z; El Harroudi T; Aissaoui S; Boukhatem N
    BMC Cancer; 2018 Mar; 18(1):292. PubMed ID: 29544444
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Fascin-1 Is a Novel Prognostic Biomarker Associated With Tumor Invasiveness in Adrenocortical Carcinoma.
    Poli G; Ruggiero C; Cantini G; Canu L; Baroni G; Armignacco R; Jouinot A; Santi R; Ercolino T; Ragazzon B; Assie G; Mannelli M; Nesi G; Lalli E; Luconi M
    J Clin Endocrinol Metab; 2019 May; 104(5):1712-1724. PubMed ID: 30476173
    [TBL] [Abstract][Full Text] [Related]  

  • 9. miR-145 and miR-133a function as tumour suppressors and directly regulate FSCN1 expression in bladder cancer.
    Chiyomaru T; Enokida H; Tatarano S; Kawahara K; Uchida Y; Nishiyama K; Fujimura L; Kikkawa N; Seki N; Nakagawa M
    Br J Cancer; 2010 Mar; 102(5):883-91. PubMed ID: 20160723
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The crucial role of fascin-1 in the pathogenesis, metastasis, and chemotherapeutic resistance of breast cancer.
    Abdullah AR; Gamal El-Din AM; El-Mahdy HA; Ismail Y; El-Husseiny AA
    Pathol Res Pract; 2024 Feb; 254():155079. PubMed ID: 38219494
    [TBL] [Abstract][Full Text] [Related]  

  • 11. ADRA2A Germline Gene Polymorphism is Associated to the Severity, but not to the Risk, of Breast Cancer.
    Kaabi B; Belaaloui G; Benbrahim W; Hamizi K; Sadelaoud M; Toumi W; Bounecer H
    Pathol Oncol Res; 2016 Apr; 22(2):357-65. PubMed ID: 26563278
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The role and regulatory mechanism of FSCN1 in breast tumorigenesis and progression.
    Chang D; Liu XX; Liu R; Sun JW
    Yi Chuan; 2023 Feb; 45(2):115-127. PubMed ID: 36927659
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cytoskeletal Focal Adhesion Proteins Fascin-1 and Paxillin Are Predictors of Malignant Progression and Poor Prognosis in Human Breast Cancer.
    Omran OM; Al Sheeha M
    J Environ Pathol Toxicol Oncol; 2015; 34(3):201-12. PubMed ID: 26349603
    [TBL] [Abstract][Full Text] [Related]  

  • 14. EGFR conjunct FSCN1 as a Novel Therapeutic Strategy in Triple-Negative Breast Cancer.
    Wang CQ; Li Y; Huang BF; Zhao YM; Yuan H; Guo D; Su CM; Hu GN; Wang Q; Long T; Wang Y; Tang CH; Li X
    Sci Rep; 2017 Nov; 7(1):15654. PubMed ID: 29142206
    [TBL] [Abstract][Full Text] [Related]  

  • 15. MicroRNA-145 inhibits migration and invasion via inhibition of fascin 1 protein expression in non-small-cell lung cancer cells.
    Zhang Y; Yang X; Wu H; Zhou W; Liu Z
    Mol Med Rep; 2015 Oct; 12(4):6193-8. PubMed ID: 26238532
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Strong Correlation of MTHFR Gene Polymorphisms with Breast Cancer and its Prognostic Clinical Factors among Egyptian Females.
    Omran MH; Fotouh BE; Shousha WG; Ismail A; Ibrahim NE; Ramadan SS
    Asian Pac J Cancer Prev; 2021 Feb; 22(2):617-626. PubMed ID: 33639682
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Impact of XRCC1 genetic variants on its tissue expression and breast cancer risk: A case-control study.
    Abdel Ghafar MT; El-Rashidy MA; Gharib F; Al-Ashmawy GM
    Environ Mol Mutagen; 2021 Aug; 62(7):399-408. PubMed ID: 34331480
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The association between interleukin-1 polymorphisms and their protein expression in Chinese Han patients with breast cancer.
    Wang J; Shi Y; Wang G; Dong S; Yang D; Zuo X
    Mol Genet Genomic Med; 2019 Aug; 7(8):e804. PubMed ID: 31297985
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Long non-coding RNA ZEB1-AS1 regulates miR-200b/FSCN1 signaling and enhances migration and invasion induced by TGF-β1 in bladder cancer cells.
    Gao R; Zhang N; Yang J; Zhu Y; Zhang Z; Wang J; Xu X; Li Z; Liu X; Li Z; Li J; Kong C; Bi J
    J Exp Clin Cancer Res; 2019 Mar; 38(1):111. PubMed ID: 30823924
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Fascin is a circulating tumor marker for head and neck cancer as determined by a proteomic analysis of interstitial fluid from the tumor microenvironment.
    Lee LY; Chen YJ; Lu YC; Liao CT; Chen IH; Chang JT; Huang YC; Chen WH; Huang CC; Tsai CY; Cheng AJ
    Clin Chem Lab Med; 2015 Sep; 53(10):1631-41. PubMed ID: 25781684
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.